This experimental therapy for Parkinson’s uses a type of stem cell called an induced pluripotent stem cell, or iPSC, which is able to generate nearly any type of cell in the body — including dopamine-producing neurons. Its manufacturing is a three-step process.
1st transplant done in trial of Parkinson... - Cure Parkinson's
1st transplant done in trial of Parkinson’s cell therapy ANPD001
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
5 Replies
•
"The trial’s primary phase is expected to be completed by next year, and patients [N=9] will be assessed for five years post-transplant, with the use of imaging scans of the brain."
Steem cells failed.
Patient 1 in this trial was nice enough to join Marc's Zoom call about a month ago to share their experience with the implant. Very exciting!
Not what you're looking for?
You may also like...
Stem Cell Therapy Developed in Korea Begins Treatment for Parkinson's Disease Patients Worldwide in Japan
Biostar Stem Cell Research Institute has received approval from Japan's Ministry of Health, Labor...
1Trial of Bradykinesia Stem Cell Therapy Now Dosing Last Group
IMAC Holdings has started dosing the third and final group of participants in a Phase 1 clinical...
Phase 2 Mesenchymal Stem Cell Trial in USA
"A newly opened Phase 2 clinical trial is evaluating adult stem cells as a potentially...
MAJOR BREAKTHROUGH in "cell therapy" for PD
-------------------------------------------
“We have been investigating personalized, stem-cell...